Cancer Genetics, Inc. (CGIX) has seen some recent volatility in the stock market and its shares finished trading at $4.3300 yesterday. Traders are starting to take interest of CGIX as the shares traded as high as $5.3000 and as low as $4.3100 in the previous market session.
Cancer Genetics, Inc. (CGIX) average trading volume is 1.83M. However, in the previous market session Cancer Genetics, Inc. (CGIX) traded 230,181 shares. The First support level on CGIX is $4.00 and the First upside resistance level on CGIX is $7.47. CGIX 50-day moving average is $3.7543 and CGIX 200 day moving average is $3.3007.
Cancer Genetics, Inc. (CGIX) recent performance has been indicated by the recent movement in CGIX shares. CGIX has performed 49.83% over the past month, CGIX has performed 8.25% over the past 90 days and CGIX has shown 53.06% over the past 1 year. Cancer Genetics, Inc. (CGIX) has a 1 year range of $1.9200 to $10.3900. Cancer Genetics, Inc. (CGIX) is trading 125.52% from its 1 year low and -58.33% from its 1 year high. Cancer Genetics, Inc. (CGIX) is showing a 1.05% short float showing the quantity short in the float.
CGIX has 2.15M shares outstanding and 2.04M shares in the float. Cancer Genetics, Inc. (CGIX) currently has a market cap of $12.38M and income of -7.50M. . The market cap of Cancer Genetics, Inc. (CGIX) at $12.38M represents how many Traders own shares of CGIX and is based off the last price ($4.3300) of CGIX and the quantity of shares outstanding (2.15M) with Cancer Genetics, Inc. (CGIX).
Cancer Genetics, Inc. (CGIX) has total cash (mrq) of 2.86M, total cash per share (mrq) of 1.24, total debt of CGIX rests at 1.16M and total debt/equity (mrq) is 22.76. . Cancer Genetics, Inc. (CGIX) operating cash flow (ttm) is -5.7M, CGIX leveraged free cash flow (ttm) is 1.21M.
CGIX is trading 2.37% above (bullish) its SMA20, 23.86% above (bullish) its SMA50 and 9.86% above (bullish) its SMA200.
